Zostavax Update

by Wayne Ghesquiere on April 1, 2011

FDA has approved a broadened age range for herpes zoster vaccine (Zostavax; Merck) to include all persons aged 50 years and older (previously 60 years and older).

Leave a Comment

Previous post:

Next post: